Published in J Exp Med on December 18, 2000
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity (2002) 14.57
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science (2008) 7.87
Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell (2010) 5.28
Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med (2007) 5.09
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med (2002) 4.78
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 4.75
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol (2009) 4.51
Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 4.34
Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med (2001) 4.17
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 4.17
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 4.06
Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95
Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med (2002) 3.86
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86
Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci U S A (2004) 3.61
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med (2010) 3.43
Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J Exp Med (2004) 3.39
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med (2004) 3.30
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21
Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med (2003) 3.20
The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A (2006) 3.19
Dendritic cell homeostasis. Blood (2009) 3.18
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest (2008) 3.14
Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med (2003) 2.94
The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med (2002) 2.93
Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med (2003) 2.92
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood (2008) 2.83
A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med (2007) 2.82
Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol (2009) 2.76
CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med (2009) 2.75
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med (2012) 2.74
Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One (2009) 2.70
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 2.49
Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44
Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med (2002) 2.32
Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol (2010) 2.27
Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature (2012) 2.25
Re(de)fining the dendritic cell lineage. Nat Immunol (2012) 2.17
CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol (2005) 2.16
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape. J Clin Oncol (2010) 2.12
Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A (2009) 2.12
Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity (2010) 2.05
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A (2007) 2.04
Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest (2002) 1.98
Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity (2006) 1.95
Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med (2011) 1.95
CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2010) 1.94
Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89
The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med (2009) 1.87
A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity (2009) 1.82
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol (2010) 1.81
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A (2001) 1.79
Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol (2010) 1.78
Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci U S A (2009) 1.78
Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med (2009) 1.76
Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol (2007) 1.74
Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc Natl Acad Sci U S A (2008) 1.73
Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology (2002) 1.72
Transcriptional programming of the dendritic cell network. Nat Rev Immunol (2012) 1.70
Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol (2007) 1.70
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest (2012) 1.69
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A (2011) 1.69
Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med (2007) 1.68
In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med (2009) 1.65
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol (2011) 1.61
The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol (2010) 1.60
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med (2004) 1.56
Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens. J Am Soc Nephrol (2013) 1.54
Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A (2008) 1.53
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med (2016) 1.52
The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest (2012) 1.52
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res (2009) 1.51
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med (2002) 1.49
Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol (2005) 1.45
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44
Innate and adaptive immune response to apoptotic cells. J Autoimmun (2007) 1.42
Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells. PLoS One (2016) 1.40
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood (2007) 1.37
Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe (2012) 1.37
An IFN-gamma-IL-18 signaling loop accelerates memory CD8+ T cell proliferation. PLoS One (2008) 1.35
Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J Exp Med (2004) 1.35
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ (2007) 1.35
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood (2011) 1.35
Dendritic cells in antifungal immunity and vaccine design. Cell Host Microbe (2012) 1.35
Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest (2011) 1.33
Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity (2013) 1.33
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32
Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions. Cell (2015) 1.28
Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog (2011) 1.27
Mechanisms regulating dendritic cell specification and development. Immunol Rev (2010) 1.26
NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development. Blood (2011) 1.25
CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake. J Immunol (2012) 1.24
Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation. Front Immunol (2012) 1.23
Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci U S A (2009) 1.23
The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol (2008) 1.23
Dendritic cells and the control of immunity. Nature (1998) 56.54
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (1994) 6.73
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med (1997) 6.53
Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 6.33
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med (2000) 5.62
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med (2000) 5.11
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol (1997) 5.06
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med (1992) 4.58
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol (1999) 4.53
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol (2000) 4.41
Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev (1997) 4.41
Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature (1999) 4.13
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (1995) 3.99
Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol (1999) 3.99
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73
Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol (1997) 3.71
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med (1996) 3.66
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med (1998) 3.58
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med (1999) 3.29
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity (1995) 2.77
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med (1999) 2.77
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69
Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med (1990) 2.54
CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat Immunol (2000) 2.49
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity (1998) 2.42
Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol (1998) 2.27
Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med (2000) 2.25
Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol (1997) 2.25
Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood (1999) 2.09
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol (1998) 2.01
Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol (1997) 1.97
Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol (1976) 1.95
Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med (1996) 1.94
In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity (1996) 1.89
Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol (1999) 1.82
A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol (1996) 1.67
The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science (1999) 1.61
The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes. Eur J Immunol (1986) 1.59
Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol (1993) 1.59
Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity (1997) 1.56
Leukocyte migration: scent of the T zone. Curr Biol (2000) 1.53
Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46
The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today (1998) 1.45
Myeloid dendritic cells. J Leukoc Biol (1999) 1.40
Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med (2000) 1.39
Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J Immunol (1999) 1.34
Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J Immunol (2000) 1.29
Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med (1999) 1.28
Protective antitumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res (1996) 1.15
Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. Eur J Immunol (1998) 1.08
Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci U S A (1996) 1.04
Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. J Exp Med (2000) 0.95
CTL priming by CD8(+) and CD8(-) dendritic cells in vivo. Eur J Immunol (1999) 0.91
Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. Blood (2000) 0.91
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01
Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol (1985) 7.90
Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79
Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 6.33
Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity (1998) 6.29
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med (1975) 5.83
Selecting and maintaining a diverse T-cell repertoire. Nature (1999) 5.35
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07
In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature (1977) 4.76
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature (1975) 4.27
H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med (1978) 3.91
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature (1991) 3.80
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73
Positive selection of thymocytes. Annu Rev Immunol (1995) 3.68
Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity (1995) 3.54
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol (1977) 3.13
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J Exp Med (1988) 2.82
Correlating notch signaling with thymocyte maturation. Immunity (1998) 2.82
Cytotoxic effects of antigen- and mitogen-induced T cells on various targets. J Immunol (1975) 2.80
Differences in the surface proteins of mouse B and T cells. Proc Natl Acad Sci U S A (1975) 2.78
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med (1989) 2.74
H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell (1992) 2.70
CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med (1992) 2.62
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity (2000) 2.58
Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med (1993) 2.57
Expression and functional significance of the J11d marker on mouse thymocytes. J Immunol (1987) 2.56
Role of self-peptides in positively selecting the T-cell repertoire. Nature (1990) 2.47
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol (1994) 2.41
Hybrid antibodies can target sites for attack by T cells. Nature (1985) 2.36
Killer cells reactive to altered-self antigens can also be alloreactive. Proc Natl Acad Sci U S A (1977) 2.35
The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol Rev (1978) 2.34
Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature (1992) 2.27
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol (1993) 2.25
Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science (1990) 2.25
RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity (1998) 2.15
Antigen recognition. Class discrimination in the world of immunology. Nature (1987) 2.10
Specificity of cytotoxic T cells from athymic mice. J Exp Med (1980) 2.07
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01
Differentiation potential of subsets of CD4-8- thymocytes. Nature (1987) 2.00
Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol (1976) 1.95
H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency. Eur J Immunol (1976) 1.95
Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. J Immunol (1980) 1.86
Positive and negative selection invoke distinct signaling pathways. J Exp Med (1996) 1.86
Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol (1994) 1.85
T cell receptor antagonists and partial agonists. Immunity (1995) 1.83
Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis. J Exp Med (1982) 1.80
Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets. Proc Natl Acad Sci U S A (1985) 1.78
Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med (1993) 1.77
Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J Exp Med (1982) 1.76
Specificity and flexibility in thymic selection. Nature (1994) 1.72
Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity (1996) 1.70
Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine? J Immunol (1983) 1.67
Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens. J Exp Med (1984) 1.63
CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion. Proc Natl Acad Sci U S A (1992) 1.61
A differentiation factor required for the expression of cytotoxic T-cell function. Nature (1982) 1.56
Veto cells. Annu Rev Immunol (1988) 1.56
Evidence from in vitro studies that tolerance to self antigens is MHC-restricted. Nature (1984) 1.54
The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway. Dev Biol (2001) 1.54
Positive selection of thymocytes. Adv Immunol (1995) 1.53
Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol (2001) 1.53
The effect of 2-mercaptoethanol on murine mixed lymphocyte cultures. J Exp Med (1974) 1.52
Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (1985) 1.51
Specificity of T-cell cones illustrates altered self hypothesis. Nature (1981) 1.50
Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. J Immunol (1989) 1.49
Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes. Nature (1987) 1.48
Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity (1995) 1.47
The CD8 response on autopilot. Nat Immunol (2001) 1.45
Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur J Immunol (1992) 1.42
T-cell selection. Curr Opin Immunol (1998) 1.42
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci U S A (1986) 1.40
Self H-2 antigens influence the specificity of alloreactive cells. J Exp Med (1980) 1.40
Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med (2000) 1.39
Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol (1977) 1.39
Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200. J Exp Med (1986) 1.39
Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol (1997) 1.38
Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J Immunol (1994) 1.38
Selective activation of Lyt 2+ precursor T cells by ligation of the antigen receptor. Nature (1985) 1.38
Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann N Y Acad Sci (1988) 1.38
Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. J Immunol (1987) 1.35
Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity (1995) 1.34
Notch signaling in T cell development. Curr Opin Immunol (2000) 1.32
Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol (1997) 1.31
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
Thymocytes expressing CD8 differentiate into CD4+ cells following intrathymic injection. Proc Natl Acad Sci U S A (1988) 1.31
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol (1997) 1.30
Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun (1998) 1.26
Secretion of immune interferon and generation of cytotoxic T cell activity in nude mice are dependent on interleukin 2: age-associated endogenous production of interleukin 2 in nude mice. J Immunol (1983) 1.24
Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone. Proc Natl Acad Sci U S A (1984) 1.24
An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J Exp Med (1992) 1.24
Mouse T-cell surface glycoprotein recognised by heterologous anti-thymocyte sera and its relationship to Thy-1 antigen. Nature (1975) 1.23
Cytotoxic t-cell response to histocompatibility antigens: the role of H-2. Cold Spring Harb Symp Quant Biol (1977) 1.21
Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun (1995) 1.20
Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors. J Immunol (1975) 1.20
Primary and secondary immune responses to Listeria monocytogenes. Curr Opin Immunol (1996) 1.19
A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection. J Exp Med (1984) 1.17
Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens. J Exp Med (1985) 1.16
H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med (1998) 1.16